Current Aging Science - Online First
Description text for Online First listing goes here...
21 - 28 of 28 results
-
-
Frontotemporal Dementia, Current Diagnosis and Treatment Emphasis on Natural Products: A Review
Authors: Zulfa Nooreen, Fariha Sumayya, Pranay Wal, Awani Kumar Rai and Sudeep TandonAvailable online: 20 March 2025More LessBackgroundFrontotemporal dementia (FTD) refers to a spectrum of brain illnesses that mostly affects the frontal and temporal lobes. These regions are commonly related to personality, behaviour, and communication. It is brought on by aberrant protein aggregates, genetics and mutation. FTD most frequently affect people between the ages of 45 and 65 but can also affect young and elderly people. It is estimated that 1.0 to 15.4 per 100,000 members of the population can be affected by FTD in the near future. About 20,000 to 30,000 cases of FTD were reported in the USA alone in 2016. Presently, no specific pharmaceutical treatments for FTD have been authorized by the US Food and Drug Administration. Nowadays, various biomarkers are available for the correct diagnosis of the disease.
MethodsThe present review demonstrates the risk factors, pathogenesis, pathophysiology, diagnostic criteria and treatment of FTD using a number of synthetic and natural drugs to treat the disease and focuses on natural products used to manage the disease. The literature search was done by online databases of SciFinder, Medline, Pubmed, GoogleScholar and Scopus.
ConclusionVarious pharmacological and non-pharmacological interventions have been recorded to treat the disease. Primary treatment is a temporary reduction in the symptoms and progression of the disease. Anticholinesterase, anti-inflammatory, antioxidant compounds are gaining interest in the management of FTD. Herbal remedies and Phytoconstituents, either alone or in combination, could serve as excellent therapies for dementia with fewer adverse effects.
-
-
-
In-silico Comparative Analysis of TOP3B Protein Mammals Species with Emphasis on Heterocephalus glaber and Homo sapiens
Authors: Yuhan Ye, Muhammed Asim Ali, Yifei Zhu and Athar HussainAvailable online: 10 March 2025More LessIntroductionTOP3B (Topoisomerase III-Beta) is a DNA topoisomerase enzyme essential for managing DNA topology during various cellular processes. TOP3B knockout mice typically develop but have a shorter lifespan; however, the exact role of TOP3B is not fully understood. This study aims to investigate the diversity of TOP3B across various mammalian species, with a particular focus on comparing the naked mole-rat (Heterocephalus glaber), known for its exceptional longevity and genomic stability, and humans (Homo sapiens).
MethodsThe study analyzed 30 putative TOP3B genes across 23 mammalian species, including Heterocephalus glaber (Hgl), Octodon degus (Ode), Pongo abelii (Pab), Trachypithecus francoisi (Tfr), Cavia porcellus (Cpo), Aotus nancymaae (Ana) and Homo sapiens (Hsa). Further deep in-silico analysis was done by covering structural and functional delivery analysis.
ResultsDatabase searches revealed the presence of two transcript isoforms, X1 and X3, in the naked mole-rat (NMR) and three isoforms in humans (Hsa), while most other species exhibited one to two isoforms. Analyses of conserved domain architecture and de novo motifs indicated noticeable differences in the domain and motif patterns between the NMR and human isoforms. Additionally, multiple sequence alignment identified several mutations at critical sites in the NMR's TOP3B protein, including A46D and G47S, and five other unnamed mutations that may contribute to genomic stability. Evolutionary analyses showed that the TOP3B sequences of the NMR are closely related to those of Cavia porcellus (guinea pig) and Octodon degus (Degus). Furthermore, protein-protein interaction network analyses, along with pathway and molecular docking studies, revealed significant diversity in the interaction patterns of TOP3B between the NMR and humans.
DiscussionThe structural diversity and conserved-site mutations in Hgl’s TOP3B protein suggest a potential role in promoting genomic stability and extending lifespan. These unique structural features may contribute to the Heterocephalus glaber’s exceptional resistance to genomic instability and aging, offering insights into potential longevity mechanisms.
ConclusionThese findings suggest that structure variations and mutations in NMR’s TOP3B protein are associated with enhanced genomic stability, which may underlie its remarkable lifespan. This study provides preliminary insights into the potential function of TOP3B in genomic maintenance across species, particularly in aging and longevity.
-
-
-
Phytoextracts as Natural Anti-Aging Agents: Mechanisms and Strategies for Skin Rejuvenation
Authors: Vishakha Devi, Geeta Deswal, Ajmer Singh Grewal, Anjali Sharma and Kumar GuarveAvailable online: 03 March 2025More LessIntroduction/ObjectiveSkin aging is a complex biological process driven by intrinsic factors, such as genetics and cellular metabolism, and extrinsic factors, including environmental stressors like UV radiation, pollution, and lifestyle choices. These factors result in visible signs of aging, such as wrinkles, reduced skin elasticity, and pigmentation. This review presents the recent findings on phytoextracts as natural anti-aging agents, highlighting their bioactive compounds, mechanisms of action, and applications in skin rejuvenation.
MethodsA comprehensive literature search was conducted in databases including Scopus, PubMed, and Web of Science, focusing on articles published from 2000 to 2023. Search terms such as “phytoextracts and skin aging,” “natural antioxidants and collagen synthesis,” and “bioactive compounds and skin rejuvenation” were used. Inclusion criteria involved peer-reviewed studies on phytoextracts with experimental evidence of anti-aging effects, focusing on human and in-vitro models. Exclusion criteria included non-English articles, review papers without experimental data, and studies unrelated to skin aging. Recent research articles focusing on skin aging mechanisms and the efficacy of phytoextracts were identified. Particular attention was given to the antioxidant, anti-inflammatory, and collagen-boosting properties of phytoextracts.
ResultsThis study provides novel insights into the mechanisms through which phytoextracts counteract oxidative stress, inflammation, and extracellular matrix degradation. Notable examples include the role of resveratrol in activating longevity genes, curcumin in reducing UV-induced damage, and ginseng in improving skin elasticity. These compounds were found to exhibit potent anti-aging mechanisms through their antioxidant activity and collagen-boosting effects. Advanced delivery technologies, such as nanocarriers, enhance the efficacy of these bioactives.
ConclusionPhytoextracts demonstrate significant potential in combating skin aging by reducing oxidative stress and inflammation, and enhancing collagen production. While the results are promising, further clinical studies are required to validate their long-term efficacy and safety in skin aging management.
-
-
-
Unraveling the Memory of Falls in Older Adults: A Scoping Review
Authors: Karim Gallouj, Emin Altintas and Mohamad El HajAvailable online: 21 February 2025More LessDespite abundant research on falls in older adults, studies on the memory of falls are rare. Important issues not yet addressed include how older adults remember falls and whether these memories shape their life stories. Hence, a review was carried out in line with PRISMA guidelines. The present paper describes the MEMFA (MEMory of Falls in Aging) hypothesis, which we formulated to explain why older adults successfully integrate some memories of falls, but not others, into their life stories.
According to the MEMFA hypothesis, memories of falls in older adults are highly specific and vivid, trigger-reliving, and often have negative emotional valence. These characteristics, especially the negative emotional valence, when mediated by anxiety and/or depression, hinder the ability of older adults to extract meaning from falls, resulting in the unsuccessful integration of these memories and, ultimately, a fear of falling.
By providing a framework for studying the memory of falls, the MEMFA hypothesis will give rise to new insights into the psychological well-being of older adults and inform future interventions.
-
-
-
AI-Driven Innovations in Hearing Health: A Review of Artificial Intelligence Applications in Audiology and Hearing Technologies
Authors: S. Chitra Thara, K. Vidhya Lekshmi and N. VenkateswaramurthyAvailable online: 11 February 2025More LessHearing loss is a prevalent condition affecting over 500 million people globally, with projections estimating more than 700 million cases by 2050. Artificial intelligence (AI) holds transformative potential in audiology, enhancing diagnostic, therapeutic, and rehabilitation outcomes. This review explores the applications of AI in hearing aids, cochlear implants, sign language recognition, and tele-audiology.
A comprehensive literature review was conducted using PubMed, Google Scholar, and other academic databases. Relevant studies on AI-driven advancements in audiology were analyzed, focusing on hearing aid technologies, cochlear implants, diagnostics, and tele-audiology platforms.
AI technologies significantly enhance hearing aids through real-time personalization and adaptive algorithms. Cochlear implants leverage AI for improved speech recognition and listening comfort. AI-powered sign language systems facilitate communication through real-time gesture-to-text conversions, while tele-audiology expands care access using AI-enabled platforms. Diagnostic advancements include AI-enhanced audiometric testing and otoscopy.
AI is revolutionizing hearing healthcare by providing personalized, efficient, and accessible solutions. Its integration into audiology represents a paradigm shift, offering significant improvements in patient outcomes and quality of life.
-
-
-
Peptide Regulation of Ageing: From Experiment to Practice
Authors: A.V. Arutjunyan, I.G. Popovich, L.S. Kozina and G.A. RyzhakAvailable online: 06 February 2025More LessThe article presents an analysis of the results of many years of research devoted to the study of biological activity of peptide bioregulators at the molecular, cellular and tissue levels, as well as at the level of the organism. The study of peptide efficacy and analysis of their mechanism of action allowed the famous Russian gerontologist Vladimir Khavinson to propose the concept of peptide regulation of gene expression and protein synthesis. He developed and introduced the technology of obtaining active peptide preparations from animal tissues and also synthesized short peptides with targeted tissue-specific action, which are also capable of regulating gene activity and protein synthesis in cells.
It has been established that they stimulate cell proliferation and differentiation, can have immunomodulatory effects, and inhibit apoptosis, thus restoring tissue functions in various pathologies. It is extremely important to study the effect of peptides on the stabilization of cell metabolism and prevention of premature aging, which may contribute to the species limited life.
The review presents the results of experimental and clinical studies of peptide drugs in ageing, as well as the prospects of their use for the prevention and treatment of a number of cardiovascular, oncological, neurological, neurodegenarative, and other age-associated diseases.
-
-
-
Variability in Exercise is Linked to Improved Age-related Dysfunctions, Suggesting a Potential Role for the Constrained-Disorder Principle-based Second-Generation Artificial Intelligence System
Authors: Ehud Rinott, Tal Sigawi, Noa Hurvitz, Narmine Elkhateeb, Lilah Rinsky-Halivni and Yaron IlanAvailable online: 20 January 2025More LessObjectiveRegular physical activity (PA) promotes mental and physical health. Nevertheless, inactivity is a worldwide pandemic, and methods to augment exercise benefits are required. The constrained disorder principle (CDP) characterizes biological systems based on their inherent variability. Therefore, we aimed to investigate the association between intra-individual variability in PA and disability among non-athlete adults.
MethodsIn this retrospective analysis of the longitudinal SHARE survey, we included non-disabled adults aged >50 with at least six visits over 14 years. Self-reported PA frequency was documented bi- to triennially. Low PA intensity was defined as vigorous PA frequency less than once a week. Stable PA was described as an unchanged PA intensity in all consecutive middle observations. The primary outcome was defined as a physical limitation in everyday activities at the end of the survey. Secondary outcomes were cognitive functions, including short-term memory, long-term memory, and verbal fluency.
ResultsThe study included 2,049 non-disabled adults with a mean age of 53 and 49.1% women. In the initially high PA intensity group, variability in PA was associated with increased physical disability prevalence (23.3% vs. 33.2%, stablevs.unstable PA; P<0.01; adjusted P<0.01). In the initially low PA intensity group, variability was associated with a reduced physical disability (45.6% vs. 33.3%, stablevs.unstable PA; P=0.02; adjusted P=0.03). There were no statistically significant differences in cognitive parameters between the groups. Among individuals with the same low PA intensity at the beginning and end of follow-up, variability was associated with reduced physical disability (56.9% vs. 36.5%, stablevs.unstable PA; P=0.02; adjusted P=0.04) and improved short-term memory (score change: -0.28 vs. +0.29, stablevs.unstable PA; P=0.05).
ConclusionIncorporating variability into PA regimens of inactive adults may enhance their physical and cognitive benefits.
-
-
-
The Therapeutic Potential of Targeting the Pd-L1/Pd-1 Immune Checkpoint Pathway in Alzheimer's Disease
Available online: 06 December 2024More LessAlzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the accumulation of amyloid-β plaques, neurofibrillary tangles, and chronic neuroinflammation. Emerging evidence suggests that the PD-L1/PD-1 immune checkpoint pathway plays a critical role in modulating neuroinflammation, microglial function, and amyloid-β clearance in AD. This review summarizes the current understanding of the PD-L1/PD-1 pathway in AD and discusses its potential as a therapeutic target. Preclinical studies and clinical trials have demonstrated that targeting the PD-L1/PD-1 axis can enhance microglial phagocytosis, promote amyloid-β clearance, and reduce neuroinflammation. We examine the potential benefits and challenges of using existing immunotherapy drugs, such as anti-PD-L1 and anti-PD-1 antibodies, in the context of AD.
Additionally, we explore the development of novel, more specific agents targeting the PD-L1/PD-1 pathway, as well as potential synergistic approaches with other immunomodulatory or amyloid-β-targeting treatments. This review provides a comprehensive and up-to-date analysis of the PD-L1/PD-1 immune checkpoint pathway's role in Alzheimer's disease, highlighting its promising therapeutic potential for improving patient outcomes. Further research is warranted to optimize treatment strategies and evaluate the long-term safety and efficacy of targeting this axis in clinical settings.
-
Most Read This Month Most Read RSS feed
Most Cited Most Cited RSS feed
-
-
Polyphenols and Aging
Authors: Brannon L. Queen and Trygve O. Tollefsbol
-
- More Less